[1]
Rognoni, C., Bertolani, A. and Jommi, C. 2018. Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives. Global and Regional Health Technology Assessment. 5, 1 (Jun. 2018). DOI:https://doi.org/10.33393/grhta.2018.440.